
    
      Further information is provided in van Schalkwyk MC, Papa SE, Jeannon JP, Guerrero Urbano T,
      Spicer JF, Maher J. Design of a phase I clinical trial to evaluate intratumoral delivery of
      ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and
      neck cancer. Hum Gene Ther Clin Dev. 2013 Sep;24(3):134-42. doi: 10.1089/humc.2013.144.
      PubMed ID: 24099518
    
  